SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Emerging Infectious Agents: Do They Pose a Risk to the Safety of Transfused Blood and Blood Products?
7 references·4 citing·33 second hop
Emerging Infectious Agents: Do They Pose a Risk to the Safety of Transfused Blood and Blood Products? (2002)Emerging Infectious Agents: Do They Pose …Blood Safety in the New Millennium (2002)Blood Safety in the New Mille…Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996 (2000)Trends in Incidence and Preva…Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Nucleic acid amplification te…NAT of the United States and Canadian blood supply (2000)NAT of the United States and …The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…HIV and the blood supply: an analysis of crisis decision making. (1996)HIV and the blood supply: an …Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Risk of human immunodeficienc…Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk (2017)Emerging Infectious Diseases …Verses, viruses, and the vulnerability of the blood supply in industrialized countries (2007)Verses, viruses, and the vuln…Comparison of demographic and donation profiles and transfusion‐transmissible disease markers and risk rates in previously transfused and nontransfused blood donors (2004)Comparison of demographic and…Nucleic acid amplification technology methods used in blood donor screening (2002)Nucleic acid amplification te…Collection and transfusion of blood and blood components in the United States, 1989 (1993)The Retrovirus Epidemiology Donor Study (REDS): rationale and methods (1995)Legal, Financial, and Public Health Consequences of HIV Contamination of Blood and Blood Products in the 1980s and 1990s (2002)Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century (2012)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Exposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative (1989)Transmission of Retroviruses by Transfusion of Screened Blood in Patients Undergoing Cardiac Surgery (1989)Evaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells (1991)Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. (2002)Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States (2004)Safety of the Blood Supply in Latin America (2005)Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. (2009)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current and Emerging Infectious Risks of Blood Transfusions (2003)Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure (2010)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Severe acute respiratory syndrome coronavirus‐2: implications for blood safety and sufficiency (2020)Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe (2002)First report of human immunodeficiency virus transmission via an RNA‐screened blood donation (2004)Application de la biologie moléculaire à la sécurité virale transfusionnelle : le dépistage génomique viral (2003)The mantra of blood safety: time for a new tune? (2004)HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas® TaqScreen MPX test in seroconverting donors (2007)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)The risks and benefits of accepting men who have had sex with men as blood donors (2003)Emerging Infectious Threats to the Blood Supply (2004)No evidence of a significantly increased risk of transfusion‐transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12‐month deferral for men who have had sex with men (CME) (2010)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2000Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996287 cited
  • 2000Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases218 cited
  • 1991Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening177 cited
  • 2000NAT of the United States and Canadian blood supply142 cited
  • 1996HIV and the blood supply: an analysis of crisis decision making.132 cited
  • 2002Blood Safety in the New Millennium77 cited

Cited by

  • 2017Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk33 cited
  • 2002Nucleic acid amplification technology methods used in blood donor screening33 cited
  • 2004Comparison of demographic and donation profiles and transfusion‐transmissible disease markers and risk rates in previously transfused and nontransfused blood donors17 cited
  • 2007Verses, viruses, and the vulnerability of the blood supply in industrialized countries13 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work